Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading ARNA News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.87% | 73.36 | 0.9% | $725.27m | |
| AMGN | Amgen Inc. | 0.66% | 180.37 | 1.1% | $594.92m | |
| CELG | Celgene Corporation | 1.20% | 136.62 | 1.1% | $588.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.53% | 519.60 | 2.7% | $543.76m | |
| BIIB | Biogen Inc. | 0.65% | 283.78 | 1.2% | $408.07m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.21% | 159.36 | 1.9% | $369.36m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.68% | 129.44 | 1.9% | $285.29m | |
| CLVS | Clovis Oncology, Inc. | 3.69% | 86.94 | 18.0% | $175.33m | |
| TSRO | TESARO, Inc. | 3.44% | 128.28 | 14.7% | $169.88m | |
| INCY | Incyte Corporation | 1.52% | 132.43 | 2.6% | $169.02m | |
| ILMN | Illumina, Inc. | -0.43% | 173.13 | 3.5% | $159.15m | |
| EXEL | Exelixis, Inc. | 2.13% | 27.32 | 6.5% | $156.62m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.38% | 87.56 | 4.4% | $131.55m | |
| KITE | Kite Pharma, Inc. | 1.78% | 107.31 | 16.1% | $121.77m | |
| BLUE | Bluebird Bio, Inc. | 0.10% | 97.40 | 19.3% | $117.43m |
Company Profile
Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.